CV vs SPGI · rev $3.5M vs P/E 27, rev $15.34B
CapsoVision, Inc. Common Stock (CV) versus S&P Global Inc (SPGI) — a side-by-side from cached financials, not a winner call.
CapsoVision, Inc. Common Stock (CV) is a medical devices company listed on US.
S&P Global Inc (SPGI) is a financial data & stock exchanges company listed on NYSE.
Latest reported CV revenue for 2025-09-30 was $3.5M. Net income was -$7.9M. Revenue was up 6.7% from 2025-06-30 to 2025-09-30. CV currently screens at market cap $359.2M.
Latest reported SPGI revenue for 2025-12-31 was $15.34B. Net income was $4.47B. Revenue was up 7.9% from 2024-12-31 to 2025-12-31. SPGI currently screens at market cap $127.50B and trailing P/E 27.2.
CV currently screens at market cap $359.2M. SPGI currently screens at market cap $127.50B and trailing P/E 27.2.
Not investment advice. Open the CV and SPGI stock pages for the full models.
Not investment advice.